US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

683.09

-8.2634-1.20%

Number of Gainers:1

Number of Losers:3

Number of Flat:- -

PE:- -

High:690.00

Open:690.00

Low:673.57

Close:691.35

Volume:11.32M

Turnover:179.14M

Market Cap:21.86B

Float Cap:16.81B

Loading ...

Beam Therapeutics Reports Initial Phase 1/2 Data for BEAM-301 in Glycogen Storage Disease Type Ia Trial

Tempus AI Unit Ambry Genetics Launches GenomeNext Whole-Genome Sequencing Test for Rare Diseases

DeciBio Ventures Flags Pharma Services Sector Push into AI-Enabled Clinical Development in Q3 2026 Roundup

Is Expanded Cancer Therapy Collaboration Altering The Investment Case For Tempus AI (TEM)?

Simply Wall St.

Review & Preview: Birthday Bull

Recursion, General Mills, Star Bulk, Lennar, Hershey Insider Shocks

Crispr Therapeutics General Counsel James R. Kasinger Disposes of 1,990 Common Shares Worth $119,481.19

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2026

Top Recursion Pharma Insider Makes a Major Move With His Shares

Cathie Wood’s ARK Investment buys 1.9M shares of Recursion Pharmaceuticals today

Recursion Director Robert Hershberg Sells 25,000 Common Shares for $125,000

Moderna, Merck Climb on Collaboration with Tempus

Tempus AI announces multi-year collaboration with Moderna, Merck

Tempus Expands Multi-Year Collaboration with Moderna, Merck on V940 Melanoma Vaccine Commercialization Support

Tempus - Announces Expanded Multi-Year Collaboration for Intismeran Autogene Commercialization

THOMSON REUTERS

Tempus: to Also Provide Ngs Services to Support Intismeran Autogene Design and Manufacturing Process

THOMSON REUTERS

Tempus: to Manage Collection & Transfer of Tumor Tissue & Blood Samples Needed for Next-Generation Sequencing

THOMSON REUTERS

Tempus - Financial Terms of Collaboration not Disclosed

THOMSON REUTERS

Tempus Announces Multi-Year Collaboration with Moderna and Merck

THOMSON REUTERS

Personalis-Tempus AI Deal Clears US Antitrust Waiting Period Under HSR Act

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketd.com/stock/BK4611/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":683.0871,"timestamp":1791906361070,"preClose":691.35046,"halted":0,"volume":11321879,"delay":0,"changeRate":-0.011953,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-8.263367,"latestTime":"10-13 11:46:01 EDT","open":690.0038,"high":690.0038,"low":673.565,"amount":179142216.964356,"amplitude":0.023778,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791921600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.478503,"peRate":-17.442753,"turnoverRate":0.013772,"increases":1,"decrements":3,"flats":0,"marketCap":21856304768,"floatMarketCap":16812383232},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":690.0038,"amplitude":0.023778,"preClose":691.35046,"low":673.565,"pbRate":"5.478503","latestPrice":683.0871,"volume":11321879,"delay":0,"open":690.0038,"prevYearClose":658.3995,"prevWeekClose":721.3771,"prevMonthClose":771.3898,"prevQuarterClose":771.3898,"fiveDayClose":732.2306,"twentyDayClose":673.3496,"sixtyDayClose":562.2883,"secType":"PLATE","market":"US","turnoverRate":0.013772,"peRate":-17.442753,"marketCap":21856304768,"floatMarketCap":16812383232,"timestamp":1791906361070,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":1,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2675550733","title":"Beam Therapeutics Reports Initial Phase 1/2 Data for BEAM-301 in Glycogen Storage Disease Type Ia Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2675550733","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675550733?lang=en_us&edition=fundamental","pubTime":"2026-10-13 19:05","pubTimestamp":1791889545,"startTime":"0","endTime":"0","summary":"Beam Therapeutics reports initial Phase 1/2 data for BEAM-301 in glycogen storage disease type Ia trialBeam Therapeutics flagged initial Phase 1/2 results for BEAM-301 in glycogen storage disease type","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nNDL17C6Bx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00B64PRP62.GBP","SG9999014013.SGD","BK4585","BK4505","IE00BQXX3F31.USD","BK4112","BK4556","IE00BGHQF748.EUR","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BCDF","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","BEAM","BK4611","LU1861558580.USD","SG9999014039.USD","BK4139","BK4535","IE00BQXX3D17.EUR","NDAQ","LU1861559042.SGD","LU0314104364.USD","SG9999014021.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","SG9999014005.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675358589","title":"Tempus AI Unit Ambry Genetics Launches GenomeNext Whole-Genome Sequencing Test for Rare Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2675358589","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675358589?lang=en_us&edition=fundamental","pubTime":"2026-10-13 18:01","pubTimestamp":1791885667,"startTime":"0","endTime":"0","summary":"Tempus AI unit Ambry Genetics launches GenomeNext whole-genome sequencing test for rare diseasesAmbry Genetics, a Tempus AI subsidiary, launched GenomeNext, a whole-genome sequencing test aimed at imp","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nNDLnXdK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","TEM","TEMC","TEMT","BK4611","BK4613","ARKG","LU1861559042.SGD","LU1861558580.USD","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675233786","title":"DeciBio Ventures Flags Pharma Services Sector Push into AI-Enabled Clinical Development in Q3 2026 Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2675233786","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675233786?lang=en_us&edition=fundamental","pubTime":"2026-10-13 17:16","pubTimestamp":1791882998,"startTime":"0","endTime":"0","summary":"DeciBio Ventures flags pharma services sector push into AI-enabled clinical development in Q3 2026 roundupDeciBio Ventures’ Q3 2026 pharma services round-up flagged accelerating AI adoption across cli","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nNDL1FyrCw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","LU1861559042.SGD","BK4613","TEMC","BK4611","LU1861558580.USD","PSNL","BK4121","TEMT","TEM","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675637331","title":"Is Expanded Cancer Therapy Collaboration Altering The Investment Case For Tempus AI (TEM)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2675637331","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675637331?lang=en_us&edition=fundamental","pubTime":"2026-10-13 15:31","pubTimestamp":1791876677,"startTime":"0","endTime":"0","summary":"On 7 October 2026, Tempus AI reported an expanded multi year collaboration to support potential commercialization of intismeran autogene V940/mRNA 4157, including management of tumor tissue and blood sample workflows and next generation sequencing services, with financial terms undisclosed.\nThe deal highlights Tempus AI's role in operational plumbing for personalized cancer treatments, where reliable sample logistics and sequencing accuracy directly affect future manufacturing readiness and...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551728-choice2-card/1789016329041","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551728-choice2-card/1789016329041"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/is-expanded-cancer-therapy-collaboration-altering-the-invest","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/is-expanded-cancer-therapy-collaboration-altering-the-invest","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1861558580.USD","LU1861559042.SGD","BK4613","TEMT","HEAL","TEMC","BK4121","ARKG","BK4611","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675859943","title":"Review & Preview: Birthday Bull","url":"https://stock-news.laohu8.com/highlight/detail?id=2675859943","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675859943?lang=en_us&edition=fundamental","pubTime":"2026-10-13 07:55","pubTimestamp":1791849300,"startTime":"0","endTime":"0","summary":"Wait & See. The bull market turned four years old on Monday, but there wasn't much of a party. Stocks ended mixed (with the bond market closed for Columbus Day and tech acting as a drag.) Investors ar","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGDX","UPRO","YSPY","FLAO","DMAX","LU0353189680.USD","SPDN","CRSP","ARKG","SPYH","CFO","MRCP","SPYQ","LU0511384066.AUD","SH","LU0289739343.SGD","IVV","LU2360106780.USD","BK4023","VOTE","BK4139","688825","LU0056508442.USD","VSL","LU1861559042.SGD","SPYU","LU2087625088.SGD","GBXB","XSPI","SPYM","BK4608","MMAX","UXAP","SPUU","GPIX","DSPY","SSO","LU0057025933.USD","BK4588","SMAX","SPXS","LU0353189763.USD","FICO","BK4611","SPXU","IE00B64QTZ34.USD","HIBL","SPXL","FDIQ","SDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674924068","title":"Recursion, General Mills, Star Bulk, Lennar, Hershey Insider Shocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2674924068","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674924068?lang=en_us&edition=fundamental","pubTime":"2026-10-10 21:01","pubTimestamp":1791637299,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($RXRX)), (($GIS)), (($SBLK)), (($LEN)) and (($HSY)). Here is a breakdown of their recent trades and th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/recursion-general-mills-star-bulk-lennar-hershey-insider-shocks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/recursion-general-mills-star-bulk-lennar-hershey-insider-shocks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","BK4088","BK4585","ITB","BK4559","LU1585245621.USD","BK4609","BK4539","GIS","BK4532","BK4548","LU0314104364.USD","LEN","LU0170899867.USD","SBLK","LU1989763690.USD","RXRX","HSY","BK4139","BK4021","LU1989763427.SGD","BK4611","BK4533","RSPS","BK4588","LU1430594728.SGD","BK4504","BK4212","BK4596"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674883808","title":"Crispr Therapeutics General Counsel James R. Kasinger Disposes of 1,990 Common Shares Worth $119,481.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2674883808","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674883808?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:35","pubTimestamp":1791495338,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics General Counsel James R. Kasinger disposes of 1,990 common shares worth $119,481.19James R. Kasinger, general counsel and secretary, exercised stock options for 1,990 common shares","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL65MQgW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Crispr Therapeutics General Counsel James R. Kasinger Disposes of 1,990 Common Shares Worth $119,481.19","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","ARKG","BK4611","BK4556","BK4585","BK4139","LU1861559042.SGD","LU1861558580.USD","CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673077189","title":"CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673077189","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673077189?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:30","pubTimestamp":1791462600,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland and BOSTON, Oct.  08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that clinical data from the Phase 1b trial of CTX310, its investigational CRISPR/Cas9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/08/3377269/0/en/crispr-therapeutics-to-present-late-breaking-data-at-the-american-heart-association-aha-scientific-sessions-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","LU1861558580.USD","AGT","IDNA","LU1861559042.SGD","BK4588","BK4107","ARKG","BK4117","BK4585","AFG","CRSP","SYNB","BK4139","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673044266","title":"Top Recursion Pharma Insider Makes a Major Move With His Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2673044266","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673044266?lang=en_us&edition=fundamental","pubTime":"2026-10-08 10:02","pubTimestamp":1791424936,"startTime":"0","endTime":"0","summary":"New insider activity at Recursion Pharmaceuticals ( ($RXRX) ) has taken place on October 7, 2026. Director Robert Hershberg of Recursion Pharmaceut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-recursion-pharma-insider-makes-a-major-move-with-his-shares-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-recursion-pharma-insider-makes-a-major-move-with-his-shares-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RXRX","BK4539","BK4548","BK4139","BK4611","BK4609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673462030","title":"Cathie Wood’s ARK Investment buys 1.9M shares of Recursion Pharmaceuticals today","url":"https://stock-news.laohu8.com/highlight/detail?id=2673462030","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673462030?lang=en_us&edition=fundamental","pubTime":"2026-10-08 08:05","pubTimestamp":1791417919,"startTime":"0","endTime":"0","summary":"20:03 EDT Cathie Wood’s ARK Investment buys 1.9M shares of Recursion Pharmaceuticals (RXRX) today Published first on TheFly – the ultimate source f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-1-9m-shares-of-recursion-pharmaceuticals-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-1-9m-shares-of-recursion-pharmaceuticals-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","RXRX","BK4544","BK4585","ARKK","BK4548","BK4539","BK4609","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673904321","title":"Recursion Director Robert Hershberg Sells 25,000 Common Shares for $125,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2673904321","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673904321?lang=en_us&edition=fundamental","pubTime":"2026-10-08 06:08","pubTimestamp":1791410934,"startTime":"0","endTime":"0","summary":"Recursion director Robert Hershberg sells 25,000 common shares for $125,000Recursion Pharmaceuticals director Robert Hershberg exercised stock options for 25,000 Class A shares at USD 2.22 on Oct. 6, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL3gsgPS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Recursion Director Robert Hershberg Sells 25,000 Common Shares for $125,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4609","BK4548","RXRX","BK4611","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011275","title":"Moderna, Merck Climb on Collaboration with Tempus","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011275","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011275?lang=en_us&edition=fundamental","pubTime":"2026-10-08 00:33","pubTimestamp":1791390807,"startTime":"0","endTime":"0","summary":"BUZZ-Moderna, Merck climb on collaboration with Tempus** Pharmaceutical companies ModernaMRNA.Oand MerckMRK.Oclimb 3.25% to $193.56 and 1.46% to $144.01, respectively** AI healthcare technology compan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nL6N45T116:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","LU1934455863.HKD","MRNX","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU2361044865.SGD","LU0965509010.AUD","SGXZ57979304.SGD","LU0320765489.SGD","TEMT","HEAL","IE00BSNM7G36.USD","LU2361044949.HKD","LU0203345920.USD","IYH","SG9999001176.SGD","MRNY","BK4007","LU2106854487.HKD","LU1861559042.SGD","LU1941712264.USD","BK4611","BK4568","IE00B2B36J28.USD","LU1057294990.SGD","LU1989771016.USD","LU1923622614.USD","BK4550","LU0942090050.USD","LU2125909247.SGD","LU1929549753.HKD","JDOC","LU1116320737.USD","IDNA","LU0861579265.USD","WDNA","LU1066051811.HKD","LU1699723380.USD","LU0289961442.SGD","LU0069063385.USD","LU0985320562.USD","LU2417539215.USD","BK4533","LU0098860793.USD","GNOM","LU1093756168.USD","LU2361045086.USD","PPH","LU1066051225.USD","LU1201861249.SGD","LU0965509101.SGD","IE00BLSP4239.USD","LU1035773651.USD","LU1066053197.SGD","LU0106261372.USD","LU0238689110.USD","LU0124676726.USD","LU1023059063.AUD","BK4139","LU1989772923.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","SG9999002224.SGD","LU0432979614.USD","LU2456880835.USD","SG9999002232.USD","BK4501","SG9999014559.SGD","LU2491050154.USD","LU0320765646.SGD","LU0162691827.USD","LU0868494617.USD","LU1430594728.SGD","LU2125154935.USD","FHLC","LU1291159041.SGD","SG9999014542.SGD","BK4516","LU1069347547.HKD","BK4559","LU1116320901.HKD","TEMC","IE0009355771.USD","LU1162221912.USD","TRUH","LU0265550946.USD","LU2360032135.SGD","LU1934455194.USD","SG9999001440.SGD","TEM","LU2089984988.USD","IXJ","LU1037948897.HKD","LU0965509283.SGD","SG9999001176.USD","LU0234572021.USD","LU1917777945.USD","SG9999015358.SGD","BMED","MRNA","LU2236285917.USD","LU0823416689.USD","LU0472753341.HKD","BK4551","ARKG","LU1941712348.USD","LU0070302665.USD","LU2125154778.USD","LU1037948541.HKD","LU0072461881.USD","SG9999013999.USD","LU1989772840.SGD","LU1061106388.HKD","LU0058720904.USD","IE00BBT3K403.USD","HRTS","LU0057025933.USD","LU1093756325.SGD","LU2125909593.SGD","SG9999014575.USD","XLV","LU1066051498.USD","LU0130102774.USD","LU1974910355.USD","LU2433249047.HKD","RXL","LU0211331839.USD","BK4121","LU0130517989.USD","LU0289739343.SGD","LU1585245621.USD","LU0511384066.AUD","LU2491049909.HKD","LU0868494708.USD","LU1032466523.USD","BK4585","LU0980610538.SGD","MRK","IE00BJT1NW94.SGD","LU0266013472.USD","LU1861558580.USD","LGHT","IHE","LU0006306889.USD","LU0122379950.USD","LU2324357040.USD","LU0965508806.USD","LU2023250843.SGD","IE00BN8TJ469.HKD","GDOC","LU0859254822.USD","LU2468319806.SGD","BK4613","LU2461242641.AUD","LU0289739699.SGD","LU0477156953.USD","LU0203347892.USD","LU0208291251.USD","IE00BJJMRZ35.SGD","FTXH","LU2112291526.USD","LU2023250504.SGD","IE00B1BXHZ80.USD","LU1571399168.USD","SG9999015341.SGD","BK4548","BK4588","SG9999014567.USD","LU1934455277.USD","PAWZ","LU0265550359.USD","LU1983299246.USD","LU0648001328.SGD","BK4532","VHT","LU2357627491.SGD","LU0689626769.HKD","LU2491050071.SGD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673772018","title":"Tempus AI announces multi-year collaboration with Moderna, Merck","url":"https://stock-news.laohu8.com/highlight/detail?id=2673772018","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673772018?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:35","pubTimestamp":1791376559,"startTime":"0","endTime":"0","summary":"Tempus (TEM) announced an expanded, multi-year collaboration to support the potential commercialization of intismeran autogene, a novel, potential ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-announces-multi-year-collaboration-with-moderna-merck-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-announces-multi-year-collaboration-with-moderna-merck-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","LU1923622614.USD","LU2125154935.USD","RXL","LU0211331839.USD","LU1934455863.HKD","BK4121","LU1699723380.USD","LU0124676726.USD","LU1116320901.HKD","LU1066051811.HKD","LU2461242641.AUD","IYH","LU1116320737.USD","ARKG","GDOC","IE00BJJMRZ35.SGD","LU0072461881.USD","LU1934455277.USD","HEAL","IE00BLSP4239.USD","LU1585245621.USD","BK4533","LU0266013472.USD","LU2023250843.SGD","SG9999001440.SGD","SG9999015358.SGD","LU0070302665.USD","LU0965508806.USD","BK4007","IE00BN8TJ469.HKD","BK4516","JDOC","LU0098860793.USD","LU0320765646.SGD","LU0980610538.SGD","LU2125154778.USD","LU1430594728.SGD","LU0868494617.USD","LU1201861249.SGD","SG9999013999.USD","LU1989771016.USD","LU0648001328.SGD","LU0511384066.AUD","BK4611","SG9999014567.USD","LU1571399168.USD","BK4559","MRK","BK4532","BMED","LU2361045086.USD","LU2357627491.SGD","IE00B4R5TH58.HKD","HRTS","LU0965509101.SGD","MRNA","SG9999015341.SGD","BK4588","LU0861579265.USD","LU1066051225.USD","PPH","TEMT","LU2112291526.USD","LU0203345920.USD","LU0320765489.SGD","LU1093756168.USD","LU1162221912.USD","LU1032466523.USD","LU0289961442.SGD","TRUH","LU2491049909.HKD","LU0965509010.AUD","IE000M9KFDE8.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU1291159041.SGD","LU0058720904.USD","BK4550","LU0234572021.USD","FHLC","LU0122379950.USD","LU0432979614.USD","LU2324357040.USD","SG9999014575.USD","LU2491050154.USD","IE00BBT3K403.USD","WDNA","LU2089984988.USD","LGHT","LU0965509283.SGD","LU1974910355.USD","LU0130517989.USD","IE00B1BXHZ80.USD","BK4568","LU2468319806.SGD","LU0106261372.USD","LU1093756325.SGD","LU2361044949.HKD","LU1066051498.USD","LU0208291251.USD","LU2023250504.SGD","LU1929549753.HKD","SG9999014542.SGD","SG9999002232.USD","LU2360032135.SGD","LU2236285917.USD","LU0289739343.SGD","FTXH","IE00BLSP4452.SGD","LU1861558580.USD","LU1037948541.HKD","LU1057294990.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0057025933.USD","GNOM","LU0289739699.SGD","LU1061106388.HKD","PAWZ","TEM","LU1066053197.SGD","BK4551","LU0069063385.USD","LU0689626769.HKD","LU2125909247.SGD","BK4501","LU1941712348.USD","LU1989772840.SGD","LU2417539215.USD","LU2491050071.SGD","SG9999001176.SGD","LU0162691827.USD","LU1934455194.USD","LU0238689110.USD","LU1035773651.USD","LU0265550359.USD","IE0009355771.USD","LU1861559042.SGD","LU1989772923.USD","LU2106854487.HKD","LU0265550946.USD","LU0942090050.USD","LU1037948897.HKD","XLV","IDNA","MRNX","VHT","LU0203347892.USD","BK4585","LU2361044865.SGD","LU0006306889.USD","TEMC","IHE","LU0859254822.USD","LU1023059063.AUD","MRNY","SG9999014559.SGD","LU2456880835.USD","IE00BJT1NW94.SGD","LU0130102774.USD","SG9999001176.USD","SG9999002224.SGD","IE00BSNM7G36.USD","LU0477156953.USD","BK4534","BK4613","LU2433249047.HKD","LU0868494708.USD","LU1941712264.USD","LU1917777945.USD","LU1069347547.HKD","LU1983299246.USD","LU0985320562.USD","BK4139","LU0472753341.HKD","LU2125909593.SGD","IXJ","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018110","title":"Tempus Expands Multi-Year Collaboration with Moderna, Merck on V940 Melanoma Vaccine Commercialization Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018110","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018110?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:30","pubTimestamp":1791376255,"startTime":"0","endTime":"0","summary":"Tempus expands multi-year collaboration with Moderna, Merck on V940 melanoma vaccine commercialization supportTempus expanded a multi-year collaboration with Moderna, Merck to support potential commer","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL3fGKs4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","ARKG","LU0106261372.USD","LU2089984988.USD","BK4139","PPH","IHE","BK4534","IE00BJT1NW94.SGD","LU2456880835.USD","IE00BFTCPJ56.SGD","LU2023250843.SGD","GNOM","LU0234572021.USD","IE000M9KFDE8.USD","LU2106854487.HKD","LU2361044949.HKD","LU0320765489.SGD","LU0069063385.USD","LU1941712264.USD","IYH","LU1699723380.USD","LU2112291526.USD","BK4611","LU0122379950.USD","BK4533","LU0289739343.SGD","LU1989772923.USD","LU0162691827.USD","LU2125909593.SGD","PAWZ","LU0203345920.USD","LU0265550359.USD","LU2491050071.SGD","IE00B1BXHZ80.USD","LU2491049909.HKD","SG9999014575.USD","LU0689626769.HKD","BK4588","LU0648001328.SGD","LU0861579265.USD","LU1069347547.HKD","LU1571399168.USD","TEMC","LU0098860793.USD","IXJ","WDNA","BK4550","LU2433249047.HKD","LU1983299246.USD","LU2491050154.USD","SG9999001440.SGD","LU0965509283.SGD","IDNA","LU0072461881.USD","LU1934455194.USD","LU1032466523.USD","LU1066051498.USD","LU1116320737.USD","HEAL","LU0265550946.USD","SG9999002224.SGD","LU0472753341.HKD","LU2125909247.SGD","LU0289739699.SGD","LU0942090050.USD","LU1093756325.SGD","SG9999002232.USD","LU1023059063.AUD","BK4516","BK4585","LU0058720904.USD","LU0432979614.USD","SG9999001176.USD","SG9999015341.SGD","IE00BBT3K403.USD","LU1861559042.SGD","IE00BN8TJ469.HKD","BK4532","LU0057025933.USD","LU0238689110.USD","LU2125154935.USD","LU0203347892.USD","LU0985320562.USD","MRK","LU1162221912.USD","IE00B2B36J28.USD","LU0859254822.USD","LU2125154778.USD","LU2361045086.USD","LU1035773651.USD","SG9999015358.SGD","LU1861558580.USD","BK4559","VHT","LU0868494708.USD","BK4501","LU0868494617.USD","LGHT","SG9999001176.SGD","LU1061106388.HKD","FHLC","TRUH","TEM","IE00BLSP4239.USD","LU0980610538.SGD","LU1585245621.USD","LU0320765646.SGD","LU0965509101.SGD","BK4121","LU0130517989.USD","LU0477156953.USD","LU2468319806.SGD","IE00BSNM7G36.USD","LU2361044865.SGD","HRTS","SG9999014559.SGD","LU1066053197.SGD","SGXZ57979304.SGD","LU1201861249.SGD","BK4568","LU2461242641.AUD","LU2023250504.SGD","BMED","LU0130102774.USD","IE0002141913.USD","IE0009355771.USD","SG9999014567.USD","LU1037948541.HKD","LU1066051225.USD","LU0823416689.USD","LU1057294990.SGD","LU1923622614.USD","SG9999014542.SGD","LU1989771016.USD","LU1037948897.HKD","GDOC","LU0208291251.USD","XLV","LU1093756168.USD","LU1430594728.SGD","LU1116320901.HKD","BK4548","BK4551","LU1917777945.USD","LU1066051811.HKD","LU2360032135.SGD","LU1291159041.SGD","LU0511384066.AUD","LU1941712348.USD","MRNA","LU0211331839.USD","LU2417539215.USD","LU0965508806.USD","LU1934455277.USD","LU0070302665.USD","IE00BJJMRZ35.SGD","LU0124676726.USD","JDOC","SG9999013999.USD","BK4613","MRNY","BK4007","LU2324357040.USD","RXL","IE00BLSP4452.SGD","LU0965509010.AUD","TEMT","LU0006306889.USD","LU2236285917.USD","LU2357627491.SGD","LU1974910355.USD","LU1989772840.SGD","LU0289961442.SGD","MRNX","LU1929549753.HKD","LU1934455863.HKD","IE00B4R5TH58.HKD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673181200","title":"Tempus - Announces Expanded Multi-Year Collaboration for Intismeran Autogene Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2673181200","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673181200?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:30","pubTimestamp":1791376202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUA6NYCFM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1861558580.USD","BK4121","TEM","TEMC","LU1861559042.SGD","BK4611","BK4613","ARKG","HEAL","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018458","title":"Tempus: to Also Provide Ngs Services to Support Intismeran Autogene Design and Manufacturing Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018458","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018458?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:30","pubTimestamp":1791376202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUA6NYCFM:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARKG","BK4611","LU1861558580.USD","HEAL","TEMC","LU1861559042.SGD","BK4613","TEM","TEMT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018455","title":"Tempus: to Manage Collection & Transfer of Tumor Tissue & Blood Samples Needed for Next-Generation Sequencing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018455","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018455?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:30","pubTimestamp":1791376202,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUA6NYCFM:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HEAL","ARKG","LU1861559042.SGD","TEM","TEMT","BK4611","LU1861558580.USD","BK4613","TEMC","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018173","title":"Tempus - Financial Terms of Collaboration not Disclosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018173","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018173?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:30","pubTimestamp":1791376202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUA6NYCFM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4611","ARKG","TEMT","LU1861558580.USD","LU1861559042.SGD","BK4613","BK4121","TEM","HEAL","TEMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018165","title":"Tempus Announces Multi-Year Collaboration with Moderna and Merck","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018165","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018165?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:30","pubTimestamp":1791376202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUA6NYCFM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WDNA","SGXZ57979304.SGD","BK4550","LU1989772923.USD","SG9999001176.SGD","LU1291159041.SGD","BK4501","BK4548","RXL","LU0162691827.USD","LU1162221912.USD","LU1941712264.USD","LU1066051811.HKD","LU2324357040.USD","LU2357627491.SGD","LU1093756325.SGD","LU0265550359.USD","LU2417539215.USD","LU2361044865.SGD","BK4588","XLV","LU0985320562.USD","BK4611","BK4516","BK4532","PPH","LU2360032135.SGD","IE0002141913.USD","SG9999014567.USD","BK4613","FTXH","TEMC","LU2491049909.HKD","LU0965509101.SGD","LU1069347547.HKD","VHT","IE0009355771.USD","LU2023250504.SGD","BK4585","LU0289739343.SGD","LGHT","LU0823416689.USD","SG9999013999.USD","GDOC","LU0058720904.USD","IE00BLSP4452.SGD","LU0124676726.USD","LU0069063385.USD","BK4534","LU0072461881.USD","LU1057294990.SGD","BK4139","LU1585245621.USD","LU1061106388.HKD","SG9999014542.SGD","SG9999014575.USD","BK4559","LU2491050154.USD","LU2361045086.USD","LU0234572021.USD","LU1116320901.HKD","LU0861579265.USD","BK4551","LU0106261372.USD","MRNX","LU0070302665.USD","LU0203347892.USD","IE00BSNM7G36.USD","LU0208291251.USD","LU2433249047.HKD","SG9999014559.SGD","LU1032466523.USD","IE00BFTCPJ56.SGD","LU0266013472.USD","LU2125909247.SGD","BK4533","LU1035773651.USD","LU1093756168.USD","HRTS","LU0320765646.SGD","LU0689626769.HKD","LU0238689110.USD","LU1934455194.USD","LU1201861249.SGD","LU1430594728.SGD","SG9999001440.SGD","LU2468319806.SGD","LU0320765489.SGD","ARKG","IE000M9KFDE8.USD","MRK","GNOM","LU0211331839.USD","LU0289739699.SGD","LU1923622614.USD","LU1974910355.USD","LU0859254822.USD","LU0965508806.USD","LU1917777945.USD","LU0265550946.USD","IDNA","IXJ","LU1934455277.USD","BK4568","SG9999001176.USD","LU2125909593.SGD","MRNA","LU2125154935.USD","LU0511384066.AUD","LU1571399168.USD","IE00BJT1NW94.SGD","TRUH","LU2456880835.USD","LU0648001328.SGD","SG9999015341.SGD","TEMT","LU0432979614.USD","LU0942090050.USD","IE00B2B36J28.USD","LU0130102774.USD","BK4121","LU2125154778.USD","LU2023250843.SGD","IE00B1BXHZ80.USD","LU0980610538.SGD","LU2112291526.USD","LU0098860793.USD","LU1037948897.HKD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1941712348.USD","PAWZ","LU1861558580.USD","LU0122379950.USD","IE00BBT3K403.USD","LU0057025933.USD","SG9999002232.USD","JDOC","LU2106854487.HKD","LU2089984988.USD","LU1934455863.HKD","LU1989771016.USD","LU2461242641.AUD","SG9999015358.SGD","BMED","LU0006306889.USD","HEAL","LU0868494708.USD","SG9999002224.SGD","IYH","LU1066053197.SGD","LU1989772840.SGD","LU1037948541.HKD","LU0965509283.SGD","IE00BLSP4239.USD","LU0868494617.USD","IHE","LU1929549753.HKD","BK4007","LU0472753341.HKD","IE00BN8TJ469.HKD","LU1066051225.USD","LU2491050071.SGD","LU0130517989.USD","FHLC","LU1023059063.AUD","LU0965509010.AUD","LU1983299246.USD","TEM","LU0203345920.USD","LU1699723380.USD","LU0477156953.USD","LU1861559042.SGD","LU2361044949.HKD","LU1066051498.USD","MRNY","LU2236285917.USD","LU1116320737.USD","LU0289961442.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673063950","title":"Personalis-Tempus AI Deal Clears US Antitrust Waiting Period Under HSR Act","url":"https://stock-news.laohu8.com/highlight/detail?id=2673063950","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673063950?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:07","pubTimestamp":1791317243,"startTime":"0","endTime":"0","summary":"Personalis-Tempus AI deal clears US antitrust waiting period under HSR ActTempus AI agreed to acquire Personalis through a two-step merger, leaving Personalis as an indirect wholly owned Tempus unit.T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL5GYGSc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","LU1861558580.USD","BK4611","TEM","PSNL","HEAL","BK4613","TEMT","BK4121","ARKG","TEMC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":33,"code":"91000000","status":"200"}]}}